Next quarter’s earnings estimate for GZPHF is $0.04 with a range of $0.04 to $0.04. The previous quarter’s EPS was $0.06. GZPHF beat its EPS estimate 25.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 56.93% of the time in the same period. In the last calendar year GZPHF has Underperformed its overall industry.

GZPHF Sales Forecast

The previous quarter’s earnings for GZPHF were $2.51B.

Detailed List of Analyst Forecasts

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

Laurence Tam

Morgan Stanley

$3.27→$2.79

Hold

-3.09%

Downside

Reiterated

09/17/24

Guangzhou Baiyunshan Pharma (874:HK) PT Lowered to HK$21.70 at Morgan StanleyMorgan Stanley analyst Laurence Tam lowered the price target on Guangzhou Baiyunshan Pharma (874:HK) to HK$21.70 (from HK$25.40) while maintaining a Equalweight rating.

GZPHF Analyst Recommendation Trends

Rating

Jun 24

Sep 24

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, GZPHF has received 0 Buy Ratings, 2 Hold Ratings, and 0 Sell Ratings. GZPHF average Analyst price target in the past 3 months is ―.

Each month's total comprises the sum of three months' worth of ratings.

Stocks with the Highest Top Analyst Consensus in the Healthcare Sector

xxx

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

GZPHF Stock Forecast FAQ

What is GZPHF’s average 12-month price target, according to analysts?

Currently, no data Available

What is GZPHF’s upside potential, based on the analysts’ average price target?

Currently there's no upside potential for GZPHF, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is GZPHF a Buy, Sell or Hold?

Currently, no data Available

What is Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Class H’s price target?

Currently, no data Available

What do analysts say about Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Class H?

Not enough analysts have published a price target to provide an average price target.

How can I buy shares of GZPHF?

Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing

Guangzhou Baiyunshan Pharmaceutical Holdings Company (GZPHF) Stock Forecast & Price Target

GZPHF Analyst Ratings

GZPHF Stock 12 Month Forecast

GZPHF Financial Forecast

GZPHF Earnings Forecast

GZPHF Sales Forecast

Detailed List of Analyst Forecasts​

GZPHF Analyst Recommendation Trends

GZPHF Stock Forecast FAQ

Become an Expert with TipRanks Premium

Detailed List of Analyst Forecasts